Pigmented villonodular synovitis: a comprehensive review and proposed treatment algorithm

SR Stephan, B Shallop, R Lackman, TWB Kim… - JBJS …, 2016 - journals.lww.com
Pigmented Villonodular Synovitis: A Comprehensive Review and... : JBJS Reviews
Pigmented Villonodular Synovitis: A Comprehensive Review and Proposed Treatment …

[HTML][HTML] Aetiology of Legg-Calvé-Perthes disease: A systematic review

V Pavone, E Chisari, A Vescio, C Lizzio… - World journal of …, 2019 - ncbi.nlm.nih.gov
BACKGROUND Legg-Calvé-Perthes disease (LCPD) is a clinical condition affecting the
femoral head of children during their growth. Its prevalence is set to be between 0.4/100000 …

Anti‐Interleukin‐6 therapy decreases hip synovitis and bone resorption and increases bone formation following ischemic osteonecrosis of the femoral head

Y Ren, Z Deng, V Gokani, M Kutschke… - Journal of Bone and …, 2020 - academic.oup.com
ABSTRACT Legg‐Calvé‐Perthes disease (LCPD) is a juvenile form of ischemic femoral
head osteonecrosis, which produces chronic hip synovitis, permanent femoral head …

Legg‐Calve‐Perthes disease produces chronic hip synovitis and elevation of interleukin‐6 in the synovial fluid

N Kamiya, R Yamaguchi, NS Adapala, E Chen, D Neal… - 2015 - academic.oup.com
ABSTRACT Legg‐Calvé‐Perthes disease (LCPD) is a childhood hip disorder of ischemic
osteonecrosis of the femoral head. Hip joint synovitis is a common feature of LCPD, but the …

The pathogenesis and treatment of Legg-Calvé-Perthes disease

T Ibrahim, DG Little - JBJS reviews, 2016 - journals.lww.com
Abstract➢ Legg-Calvé-Perthes disease is a childhood hip condition in which the blood
supply to the capital femoral epiphysis is interrupted, causing osteonecrosis and …

HIF-1-dependent IL-6 activation in articular chondrocytes initiating synovitis in femoral head ischemic osteonecrosis

R Yamaguchi, N Kamiya, NS Adapala, H Drissi… - JBJS, 2016 - journals.lww.com
Background: Ischemic osteonecrosis of the femoral head in children is associated with
chronic hip synovitis and increased levels of the pro-inflammatory cytokine interleukin-6 (IL …

Legg-Calvé-Perthes Disease.

S Chaudhry, D Phillips… - Bulletin of the Hospital for …, 2014 - search.ebscohost.com
The evolving knowledge on Legg-Calvé-Perthes (LCP) demonstrates the utility of studying a
rare disease system-atically by piecing together the biology and mechanics of this condition …

[HTML][HTML] Surgical treatments for Legg-Calvé-Perthes disease: comprehensive review

A Maleki, SM Qoreishy, MN Bahrami - Interactive Journal of Medical …, 2021 - i-jmr.org
Background: Legg-Calvé-Perthes disease (LCPD) is a common public health problem that
usually occurs between the ages of 4 and 8 years, but it can occur between the ages of 2 …

Interleukin-6 deletion stimulates revascularization and new bone formation following ischemic osteonecrosis in a murine model

G Kuroyanagi, NS Adapala, R Yamaguchi, N Kamiya… - Bone, 2018 - Elsevier
Abstract Legg-Calvé-Perthes disease (LCPD) is a childhood form of ischemic osteonecrosis
of the femoral head which can produce a permanent femoral head deformity and early …

Elevation of Proinflammatory Cytokine HMGB1 in the Synovial Fluid of Patients With Legg Calvé Perthes Disease and Correlation With IL 6

N Kamiya, HKW Kim - Journal of Bone and Mineral Research …, 2021 - academic.oup.com
ABSTRACT Legg Calvé Perthes disease (LCPD) is a childhood ischemic osteonecrosis
(ON) of the femoral head associated with the elevation of proinflammatory cytokine …